<code id='CB2EE4CD4D'></code><style id='CB2EE4CD4D'></style>
    • <acronym id='CB2EE4CD4D'></acronym>
      <center id='CB2EE4CD4D'><center id='CB2EE4CD4D'><tfoot id='CB2EE4CD4D'></tfoot></center><abbr id='CB2EE4CD4D'><dir id='CB2EE4CD4D'><tfoot id='CB2EE4CD4D'></tfoot><noframes id='CB2EE4CD4D'>

    • <optgroup id='CB2EE4CD4D'><strike id='CB2EE4CD4D'><sup id='CB2EE4CD4D'></sup></strike><code id='CB2EE4CD4D'></code></optgroup>
        1. <b id='CB2EE4CD4D'><label id='CB2EE4CD4D'><select id='CB2EE4CD4D'><dt id='CB2EE4CD4D'><span id='CB2EE4CD4D'></span></dt></select></label></b><u id='CB2EE4CD4D'></u>
          <i id='CB2EE4CD4D'><strike id='CB2EE4CD4D'><tt id='CB2EE4CD4D'><pre id='CB2EE4CD4D'></pre></tt></strike></i>

          Home / entertainment / hotspot

          hotspot


          hotspot

          author:leisure time    Page View:577
          Adam's take main illustration
          Molly Ferguson/STAT

          Biotech is awash in PIPEs.

          The numbers behind these privately negotiated purchases of public-company stock are astounding. By my count, there have been 30 PIPE transactions involving public biotechs and institutional investors (mostly hedge funds) that have raised $4 billion in the first two months of the year.

          advertisement

          Just this week, five biotechs have brought in a combined $950 million via PIPEs, including Denali Therapeutics raising $500 million, the largest such financing this year. Crinetics Pharmaceuticals raised $350 million.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In